Role of Deoxyribonucleoside Kinases and Deoxyribonucleotide Pool Alterations in Nucleoside Reverse Transcriptase Inhibitor Induced Mitochondrial Toxicity

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)


Volume 14, 2 Issues, 2016


Download PDF Flyer




Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Role of Deoxyribonucleoside Kinases and Deoxyribonucleotide Pool Alterations in Nucleoside Reverse Transcriptase Inhibitor Induced Mitochondrial Toxicity



Anti-Infective Agents, 2(3): 241-262.

Author(s): K. Relucio and M Holodniy.

Affiliation: AIDS Research Center, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue (132), Palo Alto, California 94304 USA.

Abstract

Adverse events secondary to mitochondrial toxicity is an emerging problem related to treatment of HIV infection with nucleoside reverse transcriptase inhibitors (NRTI). The prevailing hypothesis of mitochondrial toxicity associated with these agents is mitochondrial DNA (mtDNA) depletion as a result of inhibition of the mtDNA polymerase, DNA polymerase γ (DNA Pol γ). However, the inhibition of DNA Pol γ may not be the sole mechanism of mtDNA depletion. Recently, mutations in deoxyribonucleoside kinase (DRNK) genes have been discovered in children with mtDNA depletion syndromes. DRNK are involved in the maintenance of the mitochondrial deoxynucleotide (mtdNTP) pools and in the metabolism of NRTI, and may play a pivotal role in NRTI related mitochondrial toxicity. Studies which focus on the role DRNK in NRTI induced mtDNA depletion and mitochondrial toxicity are needed. It is possible that identifying a mutation or polymorphism in one of the DRNK enzymes could predict differential toxicities between individual and combination NRTI, and could identify which patients are at risk for NRTI-associated mitochondrial toxicity. In addition, elucidating this mechanism could lead to the development of adjunctive drugs or substrates that could ameliorate these toxicities. This review focuses on the following topics: 1) NRTI induced adverse events, 2) Mechanism of NRTI induced mitochondrial toxicity, 3) Summary of clinical and laboratory evidence, 4) Evidence for mechanisms other than DNA Pol g associated mitochondrial toxicity 5) The role of DRNK in mtDNA depletion and relation to activated NRTI induced toxicity, and 6) Considerations for future studies to elucidate the mechanism and to prevent NRTI toxicity.

Keywords:

deoxyribonucleoside kinases, deoxyribonucleotide pool, nucleoside reverse transcriptase inhibitor, mitochondrial toxicity, mtdna polymerase, dna polymerase g, mtdna depletion syndromes, mitochondrial deoxynucleotide pools.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 2
Issue Number: 3
First Page: 241
Last Page: 262
Page Count: 22
DOI: 10.2174/1568012033483060
Price: $58
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science